Tax-inducible production of CC chemokine ligand 22 by human T cell leukemia virus type 1 (HTLV-1)-Infected T cells promotes preferential transmission of HTLV-1 to CCR4-expressing CD4+ T cells

被引:63
作者
Hieshima, Kunio [1 ]
Nagakubo, Daisuke [1 ]
Nakayama, Takashi [1 ]
Shirakawa, Aiko-Konno [1 ]
Jin, Zhe [1 ]
Yoshie, Osamu [1 ]
机构
[1] Kinki Univ, Sch Med, Dept Microbiol, Osaka 5898511, Japan
关键词
D O I
10.4049/jimmunol.180.2.931
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Adult T cell leukemia is a mature CD4(+) T cell malignancy which predominantly expresses CCR4 and is etiologically associated with human T cell leukemia virus type 1 (HTLV-1). Because HTLV-1 transmission depends on close cell-cell contacts, HTLV-1-infected T cells may preferentially interact with CCR4(+)CD4(+) T cells for efficient viral transmission. In terms of gene expression and protein secretion, we found a strong correlation between HTLV-1 Tax oncoprotein and CCL22, a CCR4 ligand, in HTLV-1-infected T cells. Transient Tax expression in an HTLV-1-negative T cell line activated the CCL22 promoter and induced CCL22. Additionally, tax gene knockdown by small interference RNA reduced CCL22 expression in the infected T cells. These findings indicate that CCL22 is a cellular target gene of Tax. In chemotaxis assays, the culture supernatants of HTLV-1-infected T cells selectively attracted CCR4(+)CD4(+) T cells in PBMCs. This was blocked by pretreating the supernatants with anti-CCL22 Ab or PBMCs with a synthetic CCR4 antagonist. In coculture experiments, primary CCR4(+)CD4(+) T cells significantly adhered to Tax-expressing cells. This adhesion was blocked by the CCR4 antagonist or pertussis toxin. Interestingly, CCR4 was redistributed to the contact region, and in some cases, this was accompanied by a polarized microtubule-organizing center, which is an indicator of virological synapse formation, in the infected T cells. Finally, anti-CCL22 Ab treatment also blocked HTLV-1 transmission to primary CD4(+) T cells in coculture experiments with HTLV-1 producer cells. Thus, HTLV-1-infected T cells produce CCL22 through Tax and selectively interact with CCR4(+)CD4(+) T cells, resulting in preferential transmission of HTLV-1 to CCR4(+)CD4(+) T cells.
引用
收藏
页码:931 / 939
页数:9
相关论文
共 49 条
[1]  
Baba M, 1996, INT J CANCER, V66, P124, DOI 10.1002/(SICI)1097-0215(19960328)66:1<124::AID-IJC21>3.0.CO
[2]  
2-C
[3]   The immune control and cell-to-cell spread of human T-lymphotropic virus type 1 [J].
Bangham, CRM .
JOURNAL OF GENERAL VIROLOGY, 2003, 84 :3177-3189
[4]   Engagement of specific T-cell surface molecules regulates cytoskeletal polarization in HTLV-1-infected lymphocytes [J].
Barnard, AL ;
Igakura, T ;
Tanaka, Y ;
Taylor, GP ;
Bangham, CRM .
BLOOD, 2005, 106 (03) :988-995
[5]   Neuropilin-1 is involved in human T-cell lymphotropic virus type 1 entry [J].
Ghez, David ;
Lepelletier, Yves ;
Lambert, Sophie ;
Fourneau, Jean-Marie ;
Blot, Vincent ;
Janvier, Sebastien ;
Arnulf, Bertrand ;
van Endert, Peter M. ;
Heveker, Nikolaus ;
Pique, Claudine ;
Hermine, Olivier .
JOURNAL OF VIROLOGY, 2006, 80 (14) :6844-6854
[6]   Primary prevention of HTLV-I in Japan [J].
Hino, S ;
Katamine, S ;
Miyata, H ;
Tsuji, Y ;
Yamabe, T ;
Miyamoto, T .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1996, 13 :S199-S203
[7]   MILK-BORNE TRANSMISSION OF HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I IN RABBITS [J].
HIROSE, S ;
KOTANI, S ;
UEMURA, Y ;
FUJISHITA, M ;
TAGUCHI, H ;
OHTSUKI, Y ;
MIYOSHI, I .
VIROLOGY, 1988, 162 (02) :487-489
[8]   Control of regulatory T cell development by the transcription factor Foxp3 [J].
Hori, S ;
Nomura, T ;
Sakaguchi, S .
SCIENCE, 2003, 299 (5609) :1057-1061
[9]   Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton [J].
Igakura, T ;
Stinchcombe, JC ;
Goon, PKC ;
Taylor, GP ;
Weber, JN ;
Griffiths, GM ;
Tanaka, Y ;
Osame, M ;
Bangham, CRM .
SCIENCE, 2003, 299 (5613) :1713-1716
[10]   Human T cell leukemia virus type-I Tax activates human macrophage inflammatory protein-3α/CCL20 gene transcription via the NF-κB pathway [J].
Imaizumi, Y ;
Sugita, S ;
Yamamoto, K ;
Imanishi, D ;
Kohno, T ;
Tomonaga, M ;
Matsuyama, T .
INTERNATIONAL IMMUNOLOGY, 2002, 14 (02) :147-155